Skip to main content
HLB Therapeutics Co.,Ltd. logo

HLB Therapeutics Co.,Ltd. — Investor Relations & Filings

Ticker · 115450 ISIN · KR7115450009 KO Manufacturing
Filings indexed 444 across all filing types
Latest filing 2020-01-03 Director's Dealing
Country KR South Korea
Listing KO 115450

About HLB Therapeutics Co.,Ltd.

https://hlbtherapeutics.co.kr/en/

HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's clinical-stage pipeline focuses on addressing unmet medical needs in ophthalmology and oncology. Key development programs include RGN-259, a therapeutic agent for Dry Eye Disease and Neurotrophic Keratopathy, and OKN-007 for the treatment of Glioblastoma Multiforme. Additionally, the company is advancing a Natural Killer (NK) cell therapy through late-stage clinical trials to provide new therapeutic options for patients.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (specifically a '장내매도' or on-market sale) by an executive (구본주) of the company G-TreeBNT. This type of filing is a standard disclosure for insider trading or changes in share ownership by company directors/executives, which corresponds to the 'Director's Dealing' category.
2020-01-03 Korean
기타경영사항(특허권취득)(자율공시)
Investor Presentation Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by G-treeBNT. It details the patent name, content, and strategic implications for the company's drug development. Since it does not fit into specific categories like financial reports, M&A, or director dealings, and is a standard regulatory disclosure of a corporate event, it falls under the general regulatory filing category.
2019-12-16 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the suspension of share registration (closing of the shareholder register) for the purpose of determining shareholders for the 2020 Annual General Meeting. It does not contain full financial statements or meeting materials, but rather serves as a formal regulatory announcement of a corporate action. Given it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2019-12-12 Korean
증권발행결과(자율공시)(제10회차 CB)
Capital/Financing Update Classification · 95% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement regarding the issuance of convertible bonds (CB). It details the issuance amount, payment date, and the nature of the securities. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2019-11-22 Korean
분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '지트리비앤티' (G-treeBNT) covering the period from January 1, 2019, to September 30, 2019. It contains detailed corporate information, business descriptions, capital changes, and shareholding data, which are characteristic of a comprehensive interim financial report. It is not an announcement of a report, but the report itself, and it contains substantive financial and operational data. 9M 2019
2019-11-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically by (주)유양디앤유 in 지트리비앤티) due to exchangeable bond conversion. This falls under the category of 'Major Shareholding Notification' (MRQ).
2019-11-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.